MBX - MBX Biosciences Inc Annual Revenue Growth (Last Twelve Months)

Graphic logo of MBX Corp (MBX)

MBX Biosciences Inc faces early-stage testing risks and capital shortages while developing treatments for hypoparathyroidism. Unique peptide patents enable the company to effectively monetize hormonal therapy methods. The startup is currently scaling its portfolio for the global market, and the annual revenue growth dynamics for the TTM period on the GURU.Markets website feature this chart, where the 0.00 level captures the latest values.

Sales Growth YoY (Last Twelve Months): MBX Bio (MBX) for 11/23/2025 - 11/18/2026

MBX Biosciences (MBX) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:MBX Biosciences Inc - MBX
Mass-produced product of mbxbio.com

For MBX Biosciences Inc (MBX), which is developing a long-acting drug platform for endocrine therapy, the year-over-year (YoY) commercial revenue dynamics on a rolling basis serve as an indicator of market presence scaling. This metric calculates the percentage shift in revenue over the last 12 months relative to the previous year, filtering out short-term noise and demonstrating the actual speed of business expansion, which allows investors to assess the sustainability of demand for innovative medicines.

Competitor analysis for MBX Biosciences Inc

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)